Bellevue Asset Management »

Intra Cellular Therapies shares owned by Bellevue Asset Management

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Bellevue Asset Management from 13F filings

Historical chart of Bellevue Asset Management investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Bellevue Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Bellevue Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.5k 30 83.50
2024-09-30 $2.2k 30 73.17
2024-06-30 $2.1k 30 68.47
2024-03-31 $2.1k 30 69.20
2023-12-31 $2.1k 30 71.60
2023-09-30 $1.6k 30 52.07
2023-06-30 $1.9k 30 63.30
2023-03-31 $1.6k 30 54.13
2022-12-31 $1.6k 30 52.87
2022-09-30 $999 30 33.33
2022-06-30 $2.0k 30 66.67
2022-03-31 $2.0k 30 66.67

More positions owned by Bellevue Asset Management

First Tr Exchange-traded Risng Divd Achiv (RDVY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Capital Group Growth Etf Shs Creation Uni (CGGR)
First Tr Exchange- Traded Fst Low Oppt Etf (LMBS)
Amazon (AMZN)
Costco Wholesale Corporation (COST)
Jp Morgan Exchange Traded F Intrnl Res Eqt (JIRE)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Vanguard World Inf Tech Etf (VGT)
Tcw Etf Trust Flexible Income (FLXR)
Jp Morgan Exchange Traded F Short Dura Core (JSCP)
First Tr Exchange-traded First Tr Enh New (FTSM)
Starbucks Corporation (SBUX)
Jp Morgan Exchange Traded F Equity Premium (JEPI)

View all positions for Bellevue Asset Management

Top funds holding Intra Cellular Therapies

Huntington National Bank

View all funds holding Intra Cellular Therapies